Back
Day Range
$6.71
$7.11
52-Week Range
$2.68
$13.24
Volume
1,637,356
50D / 200D Avg
$7.61
/
$7.71
Prev Close
$6.98
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.3 | 0.3 |
| P/B | 1.4 | 2.9 |
| ROE % | -62.6 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$13.75
+97.3%
Low: $11.00
High: $18.00
Forward EPS
-$3.12
Est. Revenue
1.7 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.80
-$0.06 – $2.25
|
320 M | 2 |
| FY2029 |
-$0.01
-$0.03 – $0.00
|
220 M | 2 |
| FY2028 |
-$1.30
-$2.80 – -$0.39
|
150 M | 4 |
Key Takeaways
Debt/Equity of 0.18 — conservative balance sheet
Negative free cash flow of -198.94M
PEG of 0.61 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-62.58%
ROIC-39.88%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.18
Current Ratio7.95
Interest Coverage-33.15
Valuation
P/E Ratio
-2.33
P/B Ratio1.38
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -247.30M |
| ROE | -62.58% | ROA | -44.85% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -198.94M |
| ROIC | -39.88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.18 | Current Ratio | 7.95 |
| Interest Coverage | -33.15 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -2.33 | P/B Ratio | 1.38 |
| P/S Ratio | N/A | PEG Ratio | 0.61 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 575.53M | Enterprise Value | 540.58M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -247.30M | -215.79M | -174.28M | -118.04M | -80.87M |
| EPS (Diluted) | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 |
| Gross Profit | 0.0 | 0.0 | 0.0 | -4.58M | -4.14M |
| Operating Income | -261.63M | -234.77M | -177.08M | -121.48M | -82.76M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 551.33M | 487.72M | 646.59M | 461.19M | 543.10M |
| Total Liabilities | 135.49M | 113.21M | 91.30M | 49.96M | 44.37M |
| Shareholders' Equity | 415.84M | 374.51M | 555.29M | 411.23M | 498.73M |
| Total Debt | 76.17M | 75.87M | 60.76M | 32.84M | 33.28M |
| Cash & Equivalents | 111.12M | 74.46M | 146.59M | 105.95M | 182.52M |
| Current Assets | 495.88M | 433.67M | 592.60M | 403.98M | 483.75M |
| Current Liabilities | 62.36M | 40.44M | 33.83M | 20.76M | 14.55M |